Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices SynchroMax ET, Kalorama Information s Early Stage Drug Discovery 2004 ... Report, and Research and Markets Ion Channel Drug Discovery ... Report


Molecular Devices said last week that it has begun to ship the SynchroMax ET plate-handling robot, the latest addition to its line of microplate readers and liquid-handling systems.

According to the company, the SynchroMax ET provides walk-away automation for ELISA workstations and cell-based screening units that include the company’s SpectraMax or Gemini microplate reader, AquaMax dispenser, or Embla washer. Researchers can run up to 320 microplates in 96-, 384-, or 1,536-well formats.

Kalorama Information, a life sciences research provider, has released a new report entitled “Early Stage Drug Discovery 2004: Combi-chem and HTS Revisited.”

The report can be purchased for $2,995 at the following web address:

Research and Markets has announced the availability of its “Ion Channel Drug Discovery — Therapeutic Opportunities & Technology Progress” report.

The report identifies and analyzes advancements in ion-channel-targeted drug development and new technology. More information can be found at

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.